NEW YORK, April 2 - Gene Logic said Monday it had signed Sankyo, Japan’s second-largest pharmaceutical company, as a subscriber to its BioExpress and ToxExpress databases, bringing the total number of subscribers to 16.

Gene Logic did not disclose financial terms of the deal except to say that Sankyo had acquired the right to use the company’s databases and visualization tools throughout its research and development division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.